A
ALLO//CIK 0001737287
Allogene Therapeutics, Inc.
Market Data
$2.17+$0.43 (+24.71%)
ALLO · Last trade
Prev Close
$1.74
Range (29d)
$1.66 – $2.23
Recent Filings
- 1444.3 KBAllogene Therapeutics, Inc.Aug 21, 7:26 PM ET·0001737287-26-000023
- SCHEDULE 13G/A30.8 KBAllogene Therapeutics, Inc.Aug 14, 4:28 PM ET·0001231919-26-000912
- 10-Q8.4 MBAllogene Therapeutics, Inc.Aug 12, 4:17 PM ET·0001628280-26-056213
- 8-K213.1 KBAllogene Therapeutics, Inc.Aug 12, 4:12 PM ET·0001628280-26-056198
- SCHEDULE 13G/A38.6 KBAllogene Therapeutics, Inc.Aug 7, 8:20 PM ET·0001296549-26-000008
- SCHEDULE 13G8.0 KBAllogene Therapeutics, Inc.Aug 7, 8:33 AM ET·0000093751-26-000405
- 8-K221.2 KBAllogene Therapeutics, Inc.Jun 22, 4:05 PM ET·0001628280-26-044618
- 8-K140.2 KBAllogene Therapeutics, Inc.May 28, 5:06 PM ET·0001193125-26-245484
- 10-Q6.9 MBAllogene Therapeutics, Inc.May 13, 4:05 PM ET·0001628280-26-034585
- 8-K225.4 KBAllogene Therapeutics, Inc.May 13, 4:03 PM ET·0001628280-26-034583
Insiders
10- Amado RafaelEVP of R&D
- Barrett Elizabeth A.Director
- Belldegrun ArieDirector
- Beneski Benjamin MachinasSVP, Chief Technical Officer
- Bhavnagri VeerGeneral Counsel
- BONDERMAN DAVIDDirector, 10% Owner
- Chang David DDirector, President and CEO
- CHEN YINLIN JACKSVP, Finance
- COULTER JAMES G10% Owner
- DEYOUNG JOHN A.Director
Tickers
Addresses
business
210 EAST GRAND AVENUE
SOUTH SAN FRANCISCO, CA, 94080
mailing
210 EAST GRAND AVENUE
SOUTH SAN FRANCISCO, CA, 94080